$42.50
0.631.50%
Ultimo aggiornamento: Nov 21, 2:58 PM
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Mineralys Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Mineralys Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Mineralys Therapeutics Inc addetti ai lavori?
A Mineralys Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 213.87K azioni del valore di $12.96M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 8, 2025, RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, RA Capital Nexus Fund III LP, Peter Kolchinsky, Rajeev Shah, l'azienda DIRECTOR purchased 1.18M condivisioni per $25.5 ciascuna.
- Il giorno settembre 8, 2025, Srinivas Akkaraju, l'azienda - purchased 588.24K condivisioni per $25.5 ciascuna.
- Il giorno settembre 16, 2025, Malcom David Rodman, l'azienda CHIEF MEDICAL OFFICER sold 11.37K condivisioni per $36 ciascuna.
Statistiche sulla proprietà per Mineralys Therapeutics Inc
Numero di azioni emesse
79.140M
Azioni possedute dagli insider
1.019M
Percentuale posseduta dagli Insider
1.31%
Azioni possedute dagli investitori istituzionali
23.137M
Percentuale posseduta dagli investitori istituzionali
29.3%
Nov 13, 2025 | CFO AND SECRETARY | -13.87K | $29.49 | -$3.87M | SELL | -41.70% | 19.40K | Nov 11 | ||
Nov 13, 2025 | CHIEF EXECUTIVE OFFICER | -200.00K | $45.44 | -$9.09M | SELL | -24.06% | 631.30K | Nov 11 | ||
Nov 13, 2025 | DIRECTOR | 0.00 | $28.09 | -$536.80K | SELL-OPTIONS | 0.00% | 0.00 | Nov 13 | ||
Nov 13, 2025 | DIRECTOR | 0.00 | $28.19 | -$1.20M | SELL-OPTIONS | 0.00% | 0.00 | Nov 11 - Nov 13 | ||
Oct 15, 2025 | CFO AND SECRETARY | -10.76K | $42.01 | -$451.98K | SELL | -8.43% | 116.86K | Oct 13 | ||
Oct 15, 2025 | CHIEF EXECUTIVE OFFICER | -15.10K | $42.67 | -$644.33K | SELL | -1.78% | 831.30K | Oct 13 | ||
Oct 15, 2025 | CHIEF MEDICAL OFFICER | -10.37K | $43.01 | -$445.98K | SELL | -12.72% | 71.16K | Oct 15 | ||
Sep 16, 2025 | CHIEF MEDICAL OFFICER | -11.37K | $36.00 | -$409.27K | SELL | -12.24% | 81.52K | Sep 15 | ||
Sep 08, 2025 | — | 588.24K | $25.50 | $15.00M | BUY | 10.37% | 6.26M | Sep 04 | ||
Sep 08, 2025 | DIRECTOR | 1.18M | $25.50 | $30.00M | BUY | 19.14% | 7.32M | Sep 04 | ||
Aug 14, 2025 | CHIEF MEDICAL OFFICER | -5.02K | $7.01 | -$140.13K | SELL | -5.12% | 92.89K | Aug 12 - Aug 13 | ||
Jul 30, 2025 | CFO AND SECRETARY | -73.68K | $14.62 | -$1.08M | SELL | -35.66% | 132.93K | Jul 28 - Jul 30 | ||
Jul 15, 2025 | CHIEF EXECUTIVE OFFICER | -15.88K | $14.51 | -$230.43K | SELL | -1.84% | 846.40K | Jul 11 | ||
Jul 15, 2025 | CFO AND SECRETARY | -10.76K | $14.45 | -$155.45K | SELL | -4.95% | 206.61K | Jul 11 | ||
Jul 15, 2025 | CHIEF MEDICAL OFFICER | -5.02K | $7.84 | -$159.02K | SELL | -4.87% | 97.91K | Jul 14 | ||
Jun 16, 2025 | CHIEF MEDICAL OFFICER | -5.02K | $7.84 | -$159.08K | SELL | -4.70% | 101.65K | Jun 12 - Jun 13 | ||
May 15, 2025 | CHIEF MEDICAL OFFICER | -11.37K | $15.29 | -$173.77K | SELL | -9.63% | 106.67K | May 14 | ||
Apr 25, 2025 | DIRECTOR | 259.26K | $13.50 | $3.50M | BUY | 3.00% | 8.90M | Mar 13 | ||
Apr 15, 2025 | CHIEF MEDICAL OFFICER | -5.02K | $7.81 | -$158.33K | SELL | -4.30% | 111.69K | Apr 14 | ||
Apr 15, 2025 | CFO AND SECRETARY | -10.76K | $12.06 | -$129.68K | SELL | -4.76% | 215.34K | Apr 11 | ||
Apr 15, 2025 | CHIEF EXECUTIVE OFFICER | -15.32K | $12.19 | -$186.80K | SELL | -1.75% | 862.29K | Apr 11 | ||
Apr 03, 2025 | CHIEF MEDICAL OFFICER | -54.16K | $8.42 | -$877.27K | SELL | -31.70% | 116.70K | Apr 01 | ||
Mar 17, 2025 | 10% OWNER | 600.00K | $13.50 | $8.10M | BUY | 11.82% | 5.67M | Mar 13 | ||
Mar 17, 2025 | — | 600.00K | $13.50 | $8.10M | BUY | 11.82% | 5.67M | Mar 13 | ||
Mar 17, 2025 | DIRECTOR | 1.30M | $13.50 | $17.50M | BUY | 26.72% | 6.15M | Mar 13 | ||
Jan 15, 2025 | CFO AND SECRETARY | -10.76K | $9.10 | -$97.86K | SELL | -4.54% | 226.10K | Jan 13 | ||
Jan 15, 2025 | CHIEF EXECUTIVE OFFICER | -18.33K | $9.06 | -$166.08K | SELL | -2.05% | 877.61K | Jan 13 | ||
Nov 12, 2024 | CHIEF MEDICAL OFFICER | 5.02K | $7.91 | -$67.26K | SELL-OPTIONS | 3.69% | 140.99K | Nov 11 | ||
Nov 08, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $8.06 | -$355.55K | SELL-OPTIONS | 0.00% | 135.97K | Nov 06 | ||
Oct 15, 2024 | CFO AND SECRETARY | -10.76K | $13.57 | -$146.00K | SELL | -4.34% | 236.85K | Oct 11 | ||
Oct 15, 2024 | CHIEF EXECUTIVE OFFICER | -15.27K | $13.52 | -$206.43K | SELL | -1.68% | 895.94K | Oct 11 | ||
Jul 26, 2024 | DIRECTOR | -550.00K | $13.05 | -$7.18M | SELL | -5.98% | 8.64M | Jul 24 | ||
Jul 18, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $8.04 | -$7.31K | SELL-OPTIONS | 0.00% | 102.87K | Jul 16 | ||
Jul 12, 2024 | CFO AND SECRETARY | -10.76K | $13.14 | -$141.39K | SELL | -4.16% | 247.61K | Jul 11 | ||
Jul 12, 2024 | CHIEF EXECUTIVE OFFICER | -15.75K | $13.34 | -$210.08K | SELL | -1.70% | 911.21K | Jul 11 | ||
Jun 20, 2024 | CHIEF EXECUTIVE OFFICER | -49.31K | $12.01 | -$592.02K | SELL | -5.05% | 926.96K | Jun 17 - Jun 20 | ||
Jun 14, 2024 | CHIEF EXECUTIVE OFFICER | -72.80K | $12.70 | -$924.20K | SELL | -6.94% | 976.27K | Jun 12 - Jun 14 | ||
Jun 13, 2024 | CFO AND SECRETARY | -96.81K | $12.94 | -$1.25M | SELL | -27.48% | 255.46K | Jun 11 | ||
May 10, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $8.04 | -$1.39K | SELL-OPTIONS | 0.00% | 67.00K | May 09 | ||
Feb 14, 2024 | 10% OWNER | 555.55K | $13.50 | $7.50M | BUY | 12.29% | 5.07M | Feb 12 | ||
Nov 27, 2023 | CHIEF EXECUTIVE OFFICER | 4.25K | $5.97 | $25.36K | BUY | 0.41% | 1.05M | Nov 22 | ||
Sep 08, 2023 | CHIEF EXECUTIVE OFFICER | 2.25K | $12.08 | $27.18K | BUY | 0.22% | 1.04M | Sep 06 | ||
Aug 21, 2023 | CHIEF EXECUTIVE OFFICER | 2.25K | $12.10 | $27.23K | BUY | 0.22% | 1.04M | Aug 17 | ||
Aug 11, 2023 | CHIEF MEDICAL OFFICER | 0.00 | $6.82 | -$2.83M | SELL-OPTIONS | 0.00% | 0.00 | Aug 10 - Aug 11 | ||
Aug 11, 2023 | CHIEF EXECUTIVE OFFICER | 2.00K | $12.89 | $25.78K | BUY | 0.19% | 1.04M | Aug 11 | ||
Feb 16, 2023 | 10% OWNER | 3.22M | $16.00 | $5.00M | BUY | ∞ | 3.22M | Feb 14 | ||
Feb 16, 2023 | DIRECTOR | 3.18M | $16.00 | $20.00M | BUY | ∞ | 1.31M | Feb 14 | ||
Feb 16, 2023 | CFO, CHIEF BUS. OFF. AND SECY. | 6.25K | $16.00 | $100.00K | BUY | 1.81% | 350.81K | Feb 14 | ||
Feb 16, 2023 | DIRECTOR | 4.52M | $16.00 | $15.00M | BUY | ∞ | 4.52M | Feb 14 | ||
Feb 16, 2023 | DIRECTOR | 4.56M | $16.00 | $4.00M | BUY | 98.57% | 9.19M | Feb 14 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.